ABSTRACT Human tissue kallikrein (hK1) plays an important role in regulation of blood pressure, electrolyte and glucose transport, and renal function. To evaluate the feasibility of viral vector-mediated expression of recombinant human tissue kallikrein (rhK1) in the egg white of laying hens, human tissue kallikrein gene (hKLK1) cDNA-expression cassette was subcloned into avian adeno-associated virus (AAAV) transfer vector pAITR and transfected into AAV-293 cells with AAAV helper vector pcDNA-ARC and adenovirus helper vector pHelper. The recombinant viral particles with a typical AAAV morphology and relatively high titer were gener-
INTRODUCTION
Tissue kallikrein (EC3.4.21.35; KLK1 gene, K1 protein) is a serine protease that hydrolyzes kininogen to release kinins, triggering a broad spectrum of biologic effects such as vasodilatation (Margolis et al., 1971) , renal repair (Naicker et al., 1999) , cardiovascular protection and improvement of microcirculation (Emanuelia and Madeddu, 2003) . Human tissue kallikrein (hK1) can be purified from human urine, but its clinical application is limited due to purification difficulty and high cost. The recombinant human tissue kallikrein (rhK1) has been expressed in Escherichia coli (Angermann et al., 1989) , yeast (Chan et al., 1998) , and insect cells (Angermann et al., 1992) , but the expression levels and enzymatic activity are generally low. Therefore, K1 for clinical applications is mainly derived from porcine pancreas or submaxillary gland, which has potential side effects such as induction of immune responses and contamination of harmful pathogens. 777 ated and identified by PCR and electron microscopy. After 1 intravenous injection of each laying hen with 2 × 10 10 viral particles, oviduct-specific expression of hKLK1 cDNA was demonstrated by reverse transcription-PCR. Secretion of rhK1 into the egg white was detected by enzymatic assay from d 2, reaching the highest level of 107 U/mL in wk 3, and lasted for more than 6 wk after injection. Western blotting showed that the oviduct-expressed rhK1 had the same molecular mass with the natural enzyme. These data suggest that rAAAV can mediate high level and long-lasting transgene expression in oviduct cells, and the established expression system is useful for production of other recombinant proteins.
Adeno-associated virus (AAV) is a small singlestranded DNA virus that requires helper adenovirus or herpes virus for replication. As a gene transfer vector, AAV has advantages of nonpathogenicity, broad cell tropism, low immunogenicity, long-lasting expression, and thus has been extensively used in gene therapy studies and vaccine development (During, 1997) . In our previous studies, active rhK1 with correct molecular mass was successfully expressed in egg white by injection of egglaying hens with oviduct-specific expression vectors pOV3K and pOV5K (Gao et al., 2006; Fang et al., 2008) . Although the expression level was relatively high, the expression lasted for only about 10 d, which could not be significantly prolonged by repeated vector injection. In this study, the hKLK1 cDNA-expression cassette was subcloned into an avian adeno-associated virus (AAAV) transfer vector, and recombinant viral particles were generated by transfection of AAV-293 cells with a 3-plasmid system (Estevez and Villegsa, 2004) . After intravenous injection of laying hens with the viral particles, longlasting and oviduct-specific expression of rhK1 was demonstrated by reverse transcription (RT)-PCR and Western blotting, suggesting the usefulness of the expression system for production of recombinant proteins.
MATERIALS AND METHODS

Experimental Birds
The local Shaobo breed of laying hens at 17 mo of age was obtained from the Poultry Farm of the Institute of 
Construction of pAITR-OV5K
Two primers for amplification of hKLK1 cDNA-expression cassette were designed according to the 5′-regulatory sequence of ovalbumin gene (ov) and the poly A signal of bovine growth hormone (BGH) gene in the oviductspecific expression vector pOV5K (Fang et al., 2008) with the following sequences: 5′-CTTGGCGCGCGCAGACT-GACATGCATTTCATAGG-3′ and 5′-TCGGGGTAC-CAGCGGAAGAGCGCCCAATACG-3′. The 50-L PCR reaction contained 30 M each primer, 50 ng of pOV5K, 200 M deoxynucleoside triphosphate, and 2.5 U of Pfu DNA polymerase (Promega, Madison, WI). After denaturation at 94°C for 4 min, 30-cycle of PCR was performed using the following program: denaturation at 94°C for 45 s, annealing at 60°C for 45 s, elongation at 72°C for 3 min (10 min for the last cycle). The plasmid vector pCR-AAAV containing the complete genome of AAAV (Wang et al., 2005) was digested with restriction enzymes Pml I and Bsm BI to remove the cap and rep open reading frames of AAAV and ligated with the PCR product digested with the same enzymes, resulting in AAAV transfer vector pAITR-OV5K (Figure 1 ).
Preparation of rAAAV-KLK1
The recombinant virus, named rAAAV-KLK1, was prepared using a 3-plasmid system using previously described method (Estevez and Villegsa, 2004) . Briefly, 400 L of 300 mM CaCl 2 solution containing 4 g of AAAV transfer plasmid pAITR-OV5K, AAAV helper plasmid pcDNA-ARC (Wang et al., 2007) and adenovirus helper plasmid pHelper (Invitrogen) was mixed with equal volume of 2× N-2-hydroxyethylpiperazine-N′-2′-ethane-sulfonic acid-buffered saline (290 mM NaCl, 1.5 mM Na 2 HPO 4 , 50 mM N-2-hydroxyethylpiperazine-N′-2′-ethanesulfonic acid, pH 7.1), and added to 80% confluent AAV-293 cells in each 25T flasks. After incubation for 4 h at 37°C, 5% CO 2 , the solution was replaced with fresh Dulbecco's modified Eagle Medium supplemented with 10% fetal calf serum. After incubation for additional 72 h, the transfected cells were harvested and the supernatant was stored at −20°C as the stock virus following 3 cycles of freeze-thawing and centrifugation for 10 min at 4°C, 10,000 × g.
Purification of Viral Particles
Recombinant viral particles were purified using previously described method (Matsushita et al., 1998) . Briefly, the supernatant of the transfected cell lysate was extracted once with chloroform and viral particles in the upper phase were precipitated with 10% (wt/vol) PEG8000. After one more extraction with chloroform, the viral particles were collected by centrifugation and concentrated by 75% ethanol precipitation.
Identification of rAAAV-KLK1
Extraction of the viral DNA was performed as previously described (Synder et al., 1996) . The presence of hKLK1 cDNA in the genome of rAAAV-KLK1 was demonstrated by PCR using the following primers: 5′-TA-GAATTCCCCCCGATTCAGTCCCGGATTG-3′ and 5′-T TGCGGCCGCTCAGGAGTTCTCCGCTATGGTG-3′. The 50-L PCR reaction contained 200 M dNTP, 2 L of viral DNA template, 15 pmol each primer, and 2.5 U of Pfu DNA polymerase (Promega, Madison, WI). After denaturation at 94°C for 4 min, 30-cycle PCR was performed using the following program: denaturation at 94°C for 30 s, annealing at 62°for 30 s, and elongation at 72°C for 45 s (10 min for the final cycle). The PCR product was revealed by 0.8% agarose gel electrophoresis. The morphology and purity of the viral particles were examined by electron microscopy.
Quantification of rAAAV-KLK1
The rAAAV-KLK1 was quantified by dot blotting according to the instructions for Odyssey Infrared Imaging System (LI-COR, Biosciences, Lincoln, NE). Briefly, the nucleotide probe was generated by PCR in the presence of biotin-16-dUTP using hKLK1 cDNA as the template. Different dilutions of the viral DNA and copy-known AAAV transfer vector pAITR-OV5K were spotted in parallel on Nylon membranes (Boehringer Ingelheim GmbH, Ingelheim, Germany). After denaturation (0.5 M NaOH, 1.5 M NaCl) and neutralization (1.5 M NaCl, 1.0 M Tris- The purified rAAAV-KLK1 (1), positive control plasmid pAITR-OV5K (2), and negative control virus rAAAV-GFP (3) were amplified by PCR using hKLK1 cDNA-specific primers and the PCR products analyzed by agarose gel electrophoresis.
HCl) for 20 min, the membrane was baked at 80°C for 1 h and hybridized overnight at 68°C in hybridization buffer containing biotin-labeled hKLK1 cDNA probe. After 3 times of washing in PBS containing 0.1% Tween-20 (PBST) and blocking for 2 h at room temperature, the membrane was incubated for additional 1 h in PBST containing streptavidin IRDye 800CW (Rockland Immunochemicals, Gilbertsville, PA). The hybridization signal was scanned at 800 nm, and the number of viral genome was calculated by comparing the density of viral DNA with that of copyknown pAITR-OV5K vector, which was expressed as viral genome/mL.
Viral Injection and Enzymatic Assay
Each of 5 egg-laying hens at 17 mo of age was injected via wing vein route with 2 × 10 10 viral genomes of rAAAV-KLK1. After injection, 4 to 5 eggs from each hen were collected weekly and the egg whites were assayed for enzymatic activity as previously described using the egg white of normal hen as the control (Gao et al., 2006) . The K1 activities were calculated according to the formula U/ mL = [(⌬Es × V1/⌬Est × V2) × dilutions]/mL of egg white (where ⌬Es stands for the OD 340 change of test samples, ⌬Est for the OD 340 of porcine K1 standard, V1 for the volume of porcine K1 used, and V2 for the volume of test samples). The final values were expressed as means ± SEM of 4 to 5 eggs from each hen.
RT-PCR
Six weeks after rAAAV-KLK1 injection, experimental hens were killed, and their oviduct, heart, liver, spleen, lung, kidney, and skeletal muscle were collected for RNA extraction. Reverse transcription was performed according to the instructions for the RT-PCR Kit (SangGong, Shanghai, China). Briefly, the extracted RNA was digested for 15 min at 37°C with DNase I to remove potential contamination of viral DNA. The 20-L RT reaction contained 10 pmol of dNTP, 0.5 pmol of RNA inhibitor, 1 L of reverse transcription, 1 g of total RNA, and 10 pmol each primer. After incubation at 37°C for 60 min, 30-cycle PCR reaction was performed using the following program: denaturation at 94°C for 30 s, annealing at 62°C for 30 s, and elongation at 72°C for 45 s. The PCR product was revealed by 0.8% agarose gel electrophoresis.
Western Blotting
Fifteen milliliters of egg whites from normal and rAAAV-KLK1-injected hens at wk 3 after injection were mixed with equal volumes of 2 × SDS-PAGE loading buffer and separated on 12% SDS-PAGE following boiling for 5 min. The separated proteins were transferred to polyvinylidene dithioride membrane (F. Hoffmann-La Roche Ltd., Grenzacherstrasse, Switzerland), and Western blotting was performed according to the instructions for Odyssey Infrared Imaging System (LI-COR, Biosciences) using 1:1,000 rabbit anti-hK1 polyclonal antibody as the first antibody and 1:10,000 IRDye 800CW-conjugated goat anti-rabbit IgG (Rockland Immunochemicals) as the second antibody.
RESULTS
Generation and Identification of rAAAV-KLK1
To generate the recombinant virus rAAAV-KLK1, the hKLK1 cDNA expression cassette was amplified from oviduct-expression vector pOV5K, in which expression of the KLK1 cDNA is under the control of 1.7-kb 5′-regulatory region of ov and the poly A signal of bovine growth hormone gene (Fang et al., 2008) . The PCR product was subcloned into AAAV transfer vector pAITR, resulting in recombinant vector pAITR-OV5K (Figure 1) . By transfection of AAV-293 cells with the AAAV vector pAITR-OV5K, AAAV helper vector pcDNA-ACR, and adenovirus helper vector pHelper, the recombinant viral particles were harvested and purified. The typical AAAV particles with correct size were shown by electron microscopy. The presence of hKLK1 cDNA in the viral particles was demonstrated by PCR using hKLK1 cDNA-specific primers and the viral DNA as the template (Figure 2 ). Quantitative dot blotting showed that the purified rAAAV-KLK1 had a titer of 2.6 × 10 10 viral genome/mL. (1), heart (2), spleen (3), lung (4), kidney (5), liver (6), muscle (7) of the rAAAV-KLK1-injected hen and the oviduct of a normal hen (8) for reverse transcription-PCR using hKLK1 cDNA-specific primers.
Transcription of hKLK1 cDNA in Oviduct Cells
To demonstrate the transcription of hKLK1 cDNA in oviduct cells, different tissues of the experimental hens were collected at wk 6 after injection and total RNA was extracted for RT-PCR analysis. As Figure 3 shows, an expected size of transcript for hKLK1 cDNA was detected in the oviduct, but not in the heart, liver, spleen, lung, kidney, and skeletal muscle of virally injected hens.
Dynamic Secretion of rhK1 into Egg White
To investigate the dynamic secretion of rhK1 into egg white, after intravenous injection with 2 × 10 10 viral particles, 4 to 5 eggs were collected weekly from each hen and their thick egg whites assayed for K1 activity using normal egg white as the control. As Figure 4 shows, aver- Western blot of rhK1 expressed in the egg white of rAAAV-KLK1-injected hens. At wk 3 after rAAAV-KLK1 injection, the pooled egg whites of 5 hens (1) and normal egg white (2) were separated by 12% SDS-PAGE and probed with rabbit anti-hK1 as the first antibody and fluorescene-labeled goat anti-rabbit IgG as the second antibody. aged rhK1 activity in the pooled egg white of the recombinant viral infected hens increased to 26.3 U/mL in wk 1, reaching the highest level of 107.3 U/mL in wk 3, and then gradually decreased to 63.1 U/mL in wk 6 after viral injection (the end of the experiment), whereas no K1 activity was detected in the egg white of the control hens. The K1 activities between rAAAV-KLK1-injected group and the control group and between different weeks were significantly different (P > 0.05).
Western Blotting of rhK1
Egg whites of normal and rAAAV-KLK1-injected hens were separated on 12% SDS-PAGE and transferred to polyvinylidene dithioride membrane. After blocking, the membrane was probed with rabbit anti-hK1 antibody, and a specific protein band of about 43 kDa was revealed in the egg white of the rAAAV-KLK1-injected hen, but not in the egg white of the normal hen ( Figure 5 ).
DISCUSSION
Clinically, K1 can be used to treat hypertension and the related diseases such as myocardial infarction and cerebral ischemia (Overlack et al., 1981; Du, 1997) . Human K1 can be purified from urine, but its clinical application is limited due to purification difficulty and high cost. Although rhK1 has been successfully expressed in different expression systems, the expression levels and enzy-matic activity are generally low (Angermann et al., 1989; Angermann et al., 1992; Chan et al., 1998) . Therefore, K1 for clinic use is mainly derived from porcine pancreas with potential side effects such as induction of immune responses and contamination of harmful pathogens. In our previous experiments, rhK1 is successfully expressed in egg whites by injection of laying hens with oviductspecific expression vectors pOV3K and pOV5K. Although the expression level is relatively high, the expression lasts for only about 10 d, which cannot be significantly prolonged by repeated vector injection (Gao et al., 2006; Fang et al., 2008) .
The AAV is a promising gene transfer vector for gene therapy studies and vaccine development (During, 1997) . In our previous experiment, rAAAV was successfully generated and long-lasting expression of the GFP reporter gene demonstrated in viral-vector transduced avian cells (Wang et al., 2007) , which led us to further develop the system for expression of therapeutic proteins in chicken egg white. To this end, the hKLK1 cDNA-expression cassette was amplified by PCR from oviduct-specific expression vector pOV5K, in which expression of the hKLK1 cDNA is under the control of 1.7-kb 5′-regulatory region of ov gene and the poly A signal of BGH gene (Fang et al., 2008) . The PCR product was subcloned into AAAV transfer vector, and rAAAV-KLK1 particles with a typical AAAV morphology and relatively high titer were generated by cotransfection of AAV-293 cells. The presence of hKLK1 cDNA-expression cassette in the viral genome was demonstrated by PCR, suggesting the feasibility of the strategy for generation of rAAAV particles containing an oviduct-specific expression cassette.
Like mammalian AAV, AAAV can infect dividing and nondividing cells of multiple tissues (Grimm, 2002) . Our unpublished data showed that, after intravenous injection of laying hens, oviduct-specific expression vector or recombinant AAAV expressing the GFP reporter gene could be detected in multiple tissues including oviduct, heart, liver, skin, spleen, kidney, and skeletal muscle. In this experiment, rAAAV-KLK1 particles were injected intravenously into laying hens, which should lead to systemic distribution of the viral vector and broad infection of multiple tissues. However, RT-PCR analysis of the oviduct, heart, liver, spleen, lung, kidney, and skeletal muscle of rAAAV-KLK1-injected hens showed that the hKLK1 transcript was detected only in the oviduct, confirming the 1.7-kb 5′-regulatory sequence of ov gene was sufficient to control the oviduct-specific expression of transgenes (Fang et al., 2008) .
After intravenous injection of each hen with 2 × 10 10 particles of rAAAV-KLK1, rhK1 activity at the highest level of 107 U/mL or averaged level of ∼80 U/mL was detected in the egg white, and the expression lasted for at least 6 wk. About 25 eggs could be collected from each hen during the 6 wk of experimental time, and each egg contains ∼10 mL of thick egg white, where the rhK1 was present. Accordingly, at least 20,000 U of rhK1 could be obtained from each experimental hen. The rhK1 has the property of self-activation and a 7-fold increase in activity can be achieved by incubation of the rhK1-containing egg white for 30 min at 37°C (Gao et al., 2006) . Therefore, a total of 140,000 U of active rhK1 could be obtained from each rAAAV-KLK1-injected hen, which was sufficient for daily use of more than 300 hypertension patients (a daily dose of 450 U for treating human hypertension; Du, 1997) . Transgenic chickens are ideal bioreactors for production of pharmaceutical proteins for human use with advantages of high expression level, low cost, and more appropriate glycosylation (Lillico et al., 2005) . The transgenic bird lines can be established, and thus more uniform proteins can be produced. In our system, however, laying hens were separately infected by the recombinant virus, and some degree of heterogeneity of the protein expressed may exist due to individual variation of birds. Such proteins may induce side effects such as immune responses in human patients, in particular when parenteral administration is used. In regulatory terms, such negative aspects remain to be further defined. Presently, K1 for clinic use is mainly derived from the pancreas of commercial pigs, and thus a similar or even more severe problem also exists. However, such side effects have so far not been reported in hypertension patients after oral administration of pK1. This indicates that the therapeutic proteins produced using our expression system may be more suitable for oral administration.
In conclusion, an efficient rAAAV-mediated oviductspecific expression system has been generated. The high level and long-lasting secretion of rhK1 into egg white suggest the usefulness of the approach for expression of other recombinant proteins.
